This young entrepreneur is making affordable ventilators for the masses

The RespirAID device essentially provides "intermittent positive pressure ventilation" and its portable size allows healthcare professionals to carry it easily during transportation and emergency situ

Gautham Pasupuleti
Gautham Pasupuleti, CEO and co-founder, Biodesign Innovation Labs
Yuvraj Malik New Delhi
3 min read Last Updated : Jun 30 2020 | 4:24 PM IST
The coronavirus outbreak has exposed an acute shortage of ventilators in hospitals. India had only 48,000 such devices available to deal with the new virus, which causes severe breathing ailments. Despite the government providing 50,000 more under the PM Cares programme, overall availability is abysmally low.

In this crisis, start-ups are lending a helping hand. Bengaluru-based Biodesign Innovation Labs is one such player, which is pitching its low-cost ventilator solution to hospitals. Its flagship product RespirAID is a portable computer-powered respiratory device that can be used until the patient is put onto a mechanical ventilator.

"The coronavirus crisis has brought the spotlight on indigenous, innovative solutions like ours," says Biodesign Innovation CEO and co-founder Gautham Pasupuleti, who has been working in the field of medical device for six years and set up Biodesign Innovation in 2017 with his brother Adithya.

Previously, he was a researcher at MIT Media Lab, in Boston, US, where he developed ophthalmology devices in collaboration with hospitals and also researched on AI-based technologies for eye care and early cancer detection. During his time in the states, he founded an eye-care start-up CornealX, which is now part of Biodesign Innovation Labs. Pasupuleti is an instrumentation engineering graduate from Anna University in Chennai.

The goal behind starting Biodesign Innovations was to make medical devices more affordable in India, says Pasupuleti, adding that it received support from various forums along the way. It was supported by a grant from the Department of Biotechnology-Government of India, and Government of Karnataka, and was also selected Qualcomm Design in India challenge.

The RespirAID device essentially provides “intermittent positive pressure ventilation” and its portable size allows healthcare professionals to carry it easily during transportation and emergency situations.

It is meant to be used in place of AMBU (artificial manual breathing unit) bags, which are sometimes inconsistent and unreliable. RespirAID on the other hand has computer-operated and minimises skill dependence. This device can run for up to three hours on battery and for a few days on power support in a hospital setup. It is, however, not a replacement of ICU ventilator units and only a temporary alternative till such devices are not available.

“With a shortage of almost one million ventilators, but a staggering demand of 80 perecnt, there is an immediate need for a safe, reliable and affordable device to assist in ventilation for critical patients in secondary hospitals,” says Pasupuleti.

According to the company, respiratory problem causes 1,800-plus deaths per day in India, most of which happen to infants who are more susceptible to pneumonia, sepsis, and malaria.

Pasupuleti says now the company is in the process of installing it in hospitals. It has partnered with a private health-care company that is re-selling its solutions in hospitals in Bangalore, Chennai, and Kerala. It is also in discussions with government of Karnataka and Haryana for deployment.

For mass adoption, the company is also offering to license the portable ventilators to any company that wants to produce them on a mass scale. “Once there is a steady pipeline of orders, we will ramp up manufacturing,” said Pasupuleti.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCOVID-19PM CARES Fund

Next Story